Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSC-derived pleiotropic factors for wound healing in endonasal surgery
NCT04536233Phase 1Unknown
- Sponsor
- Chinese PLA General Hospital
- Start
- Oct 2020
- Primary completion
- Jan 2021
- Modality
- Cytokines & Interferons
01
Overview
Phase 1, randomised trial of MSCs derived pleiotropic factors in nasal trauma, deviated nasal septum, sinusitis and 1 more, sponsored by Chinese PLA General Hospital. Primary endpoint: Wound healing evaluation at 2 months. Status: unknown.
02
Drugs
MSCs derived pleiotropic factors
03
Conditions
nasal traumadeviated nasal septumsinusitisnasal polyps
Beyond the preview
Go deeper on NCT04536233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04536233.